Want to continue viewing company data?

Sign up for exclusive competitive intelligence.
Company Data Subscription $125 per month (billed Annually)
Signup to View Free Sample

Dong-A ST Co Ltd (Dong-A ST) is a pharmaceutical company. It manufactures and sells ethical drugs, medical devices, and diagnostic tests in South Korea. The company offers ethical drugs including gonadopin injection, dulastin progression-free survival, mainta injection, monotaxel injection, motilitone tablet, suganon tablet, sugamet XR tablet, closerin capsule, growtropin II and leucostim. Dong-A ST also offers diagnostic solutions for identification of Malaria, dengue combo, anti-HBs, HBsAg, Hepatitis C, HIV 1/2, Syphilis and Ebola Ag diseases. The company is also engaged in the research to develop new drugs. Dong-A ST is headquartered in Seoul, South Korea.

Headquarters South Korea

Address 64, Cheonho-Daero, Dongdaemun-Gu, Seoul, 02587


Telephone 82 2 9208111

No of Employees 1,591

Industry Pharmaceuticals and Healthcare

Ticker Symbol & Exchange 170900 ()

Revenue (2021) $518.5M 1.1% (2021 vs 2020)

EPS XXX

Net Income (2021) XXX -52.7% (2021 vs 2020)

Market Cap* $363.6M

Net Profit Margin (2021) XXX -53.3% (2021 vs 2020)

* As of and is in US$

Explore premium data & analytics

100+

Marketed Drugs

Understand Dong-A ST Co Ltd’s commercialized product portfolio to stay one step ahead of the market.

30+

Clinical Trials

Determine Dong-A ST Co Ltd go-to-market proposition and gain insight into the company’s clinical operations, recruitment, and trial strategy.

20+

Catalyst Calendar

Proactively evaluate Dong-A ST Co Ltd’s catalyst impacts to stay ahead of the competition & improve corporate planning. Bolster business development with timely opportunities.

20+

Lead Sheet

Understand when and why to target accounts of prospective leads, as well as who to reach out to, drawing on intelligence for Dong-A ST Co Ltd’s relevant decision makers and contact details.

19+

Pipeline Drugs

Identify which of Dong-A ST Co Ltd’s products will be commercialized, helping you to better contend with shifting product portfolios, and allowing you to stay one step ahead of the market.

2

Regulatory Milestones

Track drug and patent expiries along with geographies impacted.

1

Medical Marketed Products

A database of medical devices currently for sale around the world. Devices that have been approved by a regulatory authority are included.

1

Medical Clinical Trials

A database of clinical trials planned, currently ongoing, completed, suspended, withdrawn, and terminated in countries around the world.

Subscribe to Company Analytics & gain access to premium industry data & analytics Subscribe to Company Analytics & gain access to premium industry data & analytics Start Here

Products and Services

Products Services
Ethical Drugs: Supply of Artificial Cardiac Circuits
Gonadopin Injection Import and Supply of Medical Devices
Dulastin Progression-Free Survival (PFS) Supply of Micro Fixation Implants for Use in Artificial Joints (Hip, Knee and Shoulder) and Plastic Surgery
XXX XXX
XXX XXX
XXX XXX
Subscribe to Company Analytics for access to more products & services data Subscribe to Company Analytics for access to more products & services data Learn More

History

History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.

Year Event Description
2021 New Products/Services In September, the company launched IBA proton therapy device.
2021 Acquisitions/Mergers/Takeovers In September, the company acquired Japanese marketing authorization for DA-3880, a biosimilar of Darbepoetin-α licen.
2021 Contracts/Agreements In July, the company and Meiji Seika Pharma Co Ltd entered into an exclusive license agreement with Intas to commercialize DMB-3115, a proposed biosimilar to Ustekinumab.
Dive into past operations, including product releases, deals, acquisitions & more Dive into past operations, including product releases, deals, acquisitions & more Get Started
Image for loader

Competitor Comparison

Key Parameters Dong-A ST Co Ltd Yuhan Corp Hanmi Pharmaceuticals Co Ltd Hanmi Science Co Ltd Ildong Pharmaceutical Co Ltd
Headquarters South Korea South Korea South Korea South Korea South Korea
City Seoul Seoul Hwaseong Hwaseong Seoul
No. of Employees 1,591 1,594 2,095 98 1,433
Entity Type Public Public Public Public Public
Benchmark the company against the market with exclusive information on key competitors Benchmark the company against the market with exclusive information on key competitors Find out more

Key Financial Charts

Operating Margin
Operating Margin
EPS (Earnings per Share)
EPS (Earnings per Share)
Debt to Equity Ratio
Debt to Equity Ratio
Return on Assets
Return on Assets
Chart Financial activity with access to more key stats Chart Financial activity with access to more key stats Find out more
Executives
Name Position Board Since Age
Dae-Sik Eom Chief Executive Officer; Director Executive Board 2021 -
Jong-Hyeon Han Director Executive Board 2021 -
Sung-Keun Lee Director Executive Board 2020 -
Hee-Joo Choi Chairman Non Executive Board 2021 -
Keun-Soo Kim Director Non Executive Board 2019 -
Non Dignissim Eros Proin vel Convallis 2022 XX
Non Dignissim Eros Proin vel Convallis 2022 XX
Non Dignissim Eros Proin vel Convallis 2022 XX
Gain more insight into company management & employee structure with Company Analytics Gain more insight into company management & employee structure with Company Analytics Subscribe
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer